Loading...

Oryzon Genomics S.A.

0RDB.L•LSE
Healthcare
Medical - Pharmaceuticals
£2.90
£0.33(12.82%)

Oryzon Genomics S.A. (0RDB.L) Stock Chart & Performance Analysis

Explore Oryzon Genomics S.A.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
4.81%
5-Day Change
2.54%
1-Month Change
-1.74%
3-Month Change
86.18%
6-Month Change
58.99%
Year-to-Date (YTD) Change
89.93%
1-Year Change
41.50%
3-Year Change
3.85%
5-Year Change
-22.89%
All-Time (Max) Change
-39.01%

Analyzing Oryzon Genomics S.A. (0RDB.L) Trends Across Multiple Time Frames

Oryzon Genomics S.A. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Oryzon Genomics S.A. stock shows 4.81% 1-day change, indicating immediate volatility, while its 5-day change of 2.54% suggests a broader trend. Over a 1-month period, a -1.74% drop could signal a pullback, whereas a 3-month rise of 86.18% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of 58.99% and a YTD rise of 89.93% might concern investors, but a 1-year gain of 41.50% and a 3-year increase of 3.85% could indicate resilience. The 5-year surge of -22.89% highlights weak historical growth, while the all-time return of -39.01% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;